ENDRA Life Sciences Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$13.50 | -$13.50 | -$13.50 |
| Q2 2024 | 1 | -$3.50 | -$3.50 | -$3.50 |
| Q3 2024 | 1 | -$1.78 | -$1.78 | -$1.78 |
| Q4 2024 | 1 | -$1.78 | -$1.78 | -$1.78 |
| Q1 2025 | 1 | -$2.25 | -$2.25 | -$2.25 |
| Q2 2025 | 1 | -$2.25 | -$2.25 | -$2.25 |
| Q3 2025 | 1 | -$2.25 | -$2.25 | -$2.25 |
| Q4 2025 | 1 | -$2.16 | -$2.16 | -$2.16 |
ENDRA Life Sciences Inc. Earnings Date And Information
ENDRA Life Sciences Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-4 earnings per share for the quarter, missing analysts' consensus estimates of $-0.07 by $3.93. The company had revenue of 0 for the quarter and had revenue of 0 for the year. ENDRA Life Sciences Inc. has generated $-1 earnings per share over the last year ($-1.11 diluted earnings per share) and currently has a price-to-earnings ratio of -7.58. ENDRA Life Sciences Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
ENDRA Life Sciences Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2024 | Q2 2024 | -$0.07 | -$0.21 | -0.14 | $100,000 | $0 |
| 05/14/2024 | Q1 2024 | -$0.27 | -$0.26 | 0.01 | $0 | |
| 03/28/2024 | Q4 2023 | -$0.36 | -$0.14 | 0.22 | $428,408 | |
| 11/14/2023 | Q3 2023 | -$0.43 | -$0.40 | 0.03 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.55 | -$0.43 | 0.12 | $0 | |
| 05/15/2023 | Q1 2023 | -$51.00 | -$0.93 | 50.07 | $0 | |
| 03/16/2023 | Q4 2022 | -$1.03 | $0 | |||
| 11/14/2022 | Q3 2022 | -$60.00 | -$1.10 | 58.9 | $0 | |
| 08/15/2022 | Q2 2022 | -$50.00 | -$1.17 | 48.83 | $0 | |
| 05/12/2022 | Q1 2022 | -$70.00 | -$1,327,722.12 | -1327652.12 | $0 | |
| 03/30/2022 | Q4 2021 | -$1.60 | -$1.48 | 0.12 | $0 | |
| 11/15/2021 | Q3 2021 | -$70.00 | -$1.27 | 68.73 | $0 | |
| 08/12/2021 | Q2 2021 | -$70.00 | -$1.54 | 68.46 | $0 | |
| 05/17/2021 | Q1 2021 | -$70.00 | -$1.20 | 68.8 | $0 | |
| 03/25/2021 | Q4 2020 | -$140.00 | -$1.88 | 138.12 | $0 | |
| 11/16/2020 | Q3 2020 | -$160.00 | -$2.73 | 157.27 | $0 | |
| 08/14/2020 | Q2 2020 | -$5.40 | -$3.93 | 1.47 | $0 | |
| 05/14/2020 | Q1 2020 | -$6.60 | -$5.77 | 0.83 | $0 | |
| 03/26/2020 | Q4 2019 | -$350.00 | -$8.36 | 341.64 | $0 | |
| 11/13/2019 | Q3 2019 | -$190.00 | -$9.19 | 180.81 | $0 |
ENDRA Life Sciences Inc. Earnings: Frequently Asked Questions
-
When is ENDRA Life Sciences Inc.'s earnings date?
ENDRA Life Sciences Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
How can I listen to ENDRA Life Sciences Inc.'s earnings conference call?
The conference call for ENDRA Life Sciences Inc.'s latest earnings report can be listened to online.
-
How can I read ENDRA Life Sciences Inc.'s conference call transcript?
The conference call transcript for ENDRA Life Sciences Inc.'s latest earnings report can be read online.
-
How much profit does ENDRA Life Sciences Inc. generate each year?
ENDRA Life Sciences Inc. (:NDRA) has a recorded net income of $0. ENDRA Life Sciences Inc. has generated $-1.11 earnings per share over the last four quarters.
-
What is ENDRA Life Sciences Inc.'s price-to-earnings ratio?
ENDRA Life Sciences Inc. (:NDRA) has a price-to-earnings ratio of -7.58 and price/earnings-to-growth ratio is -0.42.
